Myeloma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older who have been diagnosed with a condition called monoclonal gammopathy of undetermined significance (MGUS), where certain protein levels in the blood or urine are below specific thresholds, less than 10% of bone marrow cells are abnormal plasma cells, and there are no signs of active myeloma or a related condition called amyloidosis
- Adults aged 18 or older who have been diagnosed with smoldering multiple myeloma (SMM), where certain protein levels in the blood or urine meet or exceed specific thresholds and/or between 10–60% of bone marrow cells are abnormal plasma cells, and there are no signs of active myeloma or amyloidosis
- People who are already enrolled in one of several specific clinical trials for MGUS or SMM at MD Anderson Cancer Center, or in any future MGUS or SMM trials that open at that centre (confirm with trial site for the full list of qualifying trials)
- People who speak English or Spanish
Who may not be able to join:
- People who show signs that their plasma cell condition has progressed to active myeloma, including: abnormally high calcium levels in the blood, poor kidney function, low red blood cell levels (anaemia), bone damage seen on imaging scans, 60% or more abnormal plasma cells in the bone marrow, a significantly abnormal ratio of certain proteins in the blood (free light chains), or more than one area of concern seen on MRI scans where each area is at least 5mm in size
- People diagnosed with plasma cell leukaemia, a rare and aggressive blood cancer
- People who have been assessed by their treating doctor as having significant cognitive impairment or delirium
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Melody E Becnel, M.D. Anderson Cancer Center
Phone: 832-206-9804
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Quality of life questionnaires; Quality of life questionnaires
Can't join this trial?
Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.